Eris Lifesciences Limited v. Controller Of Patents & Anr.

Patents are often seen as fortress walls protecting innovation, but every fortress has a gate, and sometimes that gate is besieged from multiple sides at once. The case of Eris Lifesciences Limited versus the Controller of Patents presents a fascinating glimpse into the procedural machinery of patent revocation in India, where timing, delays, and expiration dates can dramatically reshape the battlefield. For founders and IP professionals, this case is a reminder that the legal journey of a patent is rarely a straight line, and procedural missteps can be just as consequential as substantive arguments.

Eris Lifesciences Limited, a known player in the pharmaceutical space, found itself entangled in a legal dispute centered on Indian Patent No. 243301. The conflict took the form of two petitions, both aimed at the same objective: the revocation of the patent under Section 64 of The Patents Act, 1970. Section 64 provides a statutory pathway for any interested party to challenge the validity of a granted patent before the appropriate authority. The matter came before the court on 20 October 2022, with both petitions seeking to dismantle the patent's legal protections. Adding a layer of urgency to the proceedings was the fact that the patent's expiration was approaching, creating a ticking clock over the entire dispute.

The legal friction in this case was not primarily about the technical merits of the patent itself, but rather about the procedural conduct of the parties. Both petitions had been filed seeking revocation, and the respondents had encountered delays in filing their written statements, the formal documents through which a party sets out its defense to the claims made against it. The court was therefore called upon to decide whether these delays should be excused, or condoned, to allow the proceedings to move forward. Alongside this, several interlocutory applications, meaning applications made during the course of the proceedings for interim or procedural relief, were also pending and required the court's attention. The looming expiry of the patent added a strategic dimension to the dispute, as the parties had to weigh whether continued litigation would yield meaningful results before the patent's term ended.

The court exercised its discretion to condone the delays in filing the written statements, choosing to prioritize the substantive resolution of the revocation petitions over strict adherence to procedural timelines. The related interlocutory applications were disposed of as part of this order. However, recognizing the pressing reality of the patent's impending expiry, the court listed the matter for further hearing, signaling that the ultimate fate of Indian Patent No. 243301 would be determined in subsequent proceedings. The outcome of the revocation petitions themselves remained pending, leaving the patent's validity an open question as the expiration date drew near.

For founders, startup leaders, and IP professionals, this case underscores the critical importance of procedural diligence in patent litigation. Delays in filing written statements or responding to interlocutory applications can stall proceedings, and courts have the power to condone or refuse such delays based on the circumstances. More importantly, when challenging a patent's validity, timing is everything, especially if the patent is nearing its expiration. A revocation petition filed too late may become an academic exercise. Businesses should monitor patent timelines closely, act promptly when filing or defending against revocation petitions, and understand that procedural compliance is not a mere formality but a strategic lever that can determine the outcome of an IP dispute.